These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32376890)

  • 1. Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection.
    Liu WR; Tian MX; Tang Z; Fang Y; Zhou YF; Song SS; Jiang XF; Wang H; Tao CY; Zhou PY; Qu WF; Ding ZB; Peng YF; Zhou J; Fan J; Shi YH
    Br J Cancer; 2020 Jul; 123(1):92-100. PubMed ID: 32376890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15-lncRNA-Based Classifier-Clinicopathologic Nomogram Improves the Prediction of Recurrence in Patients with Hepatocellular Carcinoma.
    Zhang Q; Ning G; Jiang H; Huang Y; Piao J; Chen Z; Tan X; Zhang J; Liu G
    Dis Markers; 2020; 2020():9180732. PubMed ID: 33520012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and morpho-molecular classifiers for prediction of hepatocellular carcinoma prognosis and recurrence after surgical resection.
    Zhang X; Bai Y; Xu L; Zhang B; Feng S; Xu L; Zhang H; Xu L; Yang P; Niu T; Zheng S; Liu J
    Hepatol Int; 2019 Nov; 13(6):715-725. PubMed ID: 31531761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of a potent multi-mRNA signature for the prediction of early relapse in hepatocellular carcinoma.
    Cai J; Tong Y; Huang L; Xia L; Guo H; Wu H; Kong X; Xia Q
    Carcinogenesis; 2019 Jul; 40(7):840-852. PubMed ID: 31059567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical Signature Add Prognostic Value in Patients With Early and Intermediate Hepatocellular Carcinoma Underwent Curative Liver Resection.
    Bai Y; Lian Y; Chen X; Wu J; Lai J; Qiu F; Zhou S; Zhu Z; Tian Y; Wang Y; Yang Y; Yan M
    Front Oncol; 2020; 10():616263. PubMed ID: 33585243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients.
    Wang Z; Zhang N; Lv J; Ma C; Gu J; Du Y; Qiu Y; Zhang Z; Li M; Jiang Y; Zhao J; Du H; Zhang Z; Lu W; Zhang Y
    Biomed Res Int; 2020; 2020():4037639. PubMed ID: 33163533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
    Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
    Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic nomograms and risk classifications of outcomes in very early-stage hepatocellular carcinoma patients after hepatectomy.
    Feng LH; Sun HC; Zhu XD; Liu XF; Zhang SZ; Li XL; Li Y; Tang ZY
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):681-689. PubMed ID: 33189491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using multiple cytokines to predict hepatocellular carcinoma recurrence in two patient cohorts.
    Chen ZY; Wei W; Guo ZX; Peng LX; Shi M; Li SH; Xiao CZ; Zhong C; Qian CN; Guo RP
    Br J Cancer; 2014 Feb; 110(3):733-40. PubMed ID: 24495874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Nutritional Index (PNI) Predicts Tumor Recurrence of Very Early/Early Stage Hepatocellular Carcinoma After Surgical Resection.
    Chan AW; Chan SL; Wong GL; Wong VW; Chong CC; Lai PB; Chan HL; To KF
    Ann Surg Oncol; 2015 Dec; 22(13):4138-48. PubMed ID: 25801356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of purinergic P2X7 receptor expression in patients with hepatocellular carcinoma after curative resection.
    Liu H; Liu W; Liu Z; Liu Y; Zhang W; Xu L; Xu J
    Tumour Biol; 2015 Jul; 36(7):5039-49. PubMed ID: 25722111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomogram to Predict Survival of Patients With Recurrence of Hepatocellular Carcinoma After Surgery.
    He W; Peng B; Tang Y; Yang J; Zheng Y; Qiu J; Zou R; Shen J; Li B; Yuan Y
    Clin Gastroenterol Hepatol; 2018 May; 16(5):756-764.e10. PubMed ID: 29246702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
    Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
    Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long non-coding RNA-based signature predicts early recurrence in hepatocellular carcinoma.
    He S; Li JF; Tian H; Sang Y; Yang XJ; Guo GX; Yang JE
    Cancer Biomark; 2022; 34(2):309-318. PubMed ID: 34957996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
    Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
    J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SYPL1 overexpression predicts poor prognosis of hepatocellular carcinoma and associates with epithelial-mesenchymal transition.
    Chen DH; Wu QW; Li XD; Wang SJ; Zhang ZM
    Oncol Rep; 2017 Sep; 38(3):1533-1542. PubMed ID: 28731154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
    Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
    Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.